Sun Ming, Chen Zhaofu, Tan Shutao, Liu Caigang, Zhao Wenyan
Department of Urology.
Department of Breast Surgery.
Onco Targets Ther. 2018 Apr 5;11:1961-1971. doi: 10.2147/OTT.S158275. eCollection 2018.
FSIP1 plays a vital role in tumorigenesis and cancer progression. In bladder cancer, FSIP1 overexpression was associated with poor prognosis of bladder urothelial carcinoma. In this study, we investigated whether FSIP1 is essential in the progression of bladder cancer and the mechanism by which it mediates this effect.
FSIP1 expression was knocked down in bladder cancer cells using lentiviral-mediated short hairpin RNA (shRNA). FSIP1 expression was detected using Western blotting, immunohistochemistry (IHC), and quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The effects of FSIP1 knockdown on tumor cells were assessed using colony formation, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and flow cytometry (FCM) apoptosis assays in vitro and BALB/c nude mouse xenograft model in vivo.
The findings suggested that FSIP1 protein was highly expressed in bladder cancer cell lines. Knockdown of FSIP1 resulted in reduced tumor cell viability, cell cycle arrest at G/G phase and apoptosis of bladder cancer cell lines (<0.05). Moreover, knockdown of FSIP1 expression suppressed the tumor formation and growth of bladder cancer xenografts (<0.05). At the gene level, knockdown of FSIP1 expression downregulated the activity of the PI3K/AKT signaling pathway.
This study demonstrated that knockdown of FSIP1 suppressed bladder cancer cell malignant behaviors in vitro and in vivo through the inhibition of the PI3K/AKT signaling pathway, suggesting that targeting FSIP1 could be further evaluated as a potential therapeutic strategy in bladder cancer.
FSIP1在肿瘤发生和癌症进展中起着至关重要的作用。在膀胱癌中,FSIP1的过表达与膀胱尿路上皮癌的不良预后相关。在本研究中,我们调查了FSIP1在膀胱癌进展中是否必不可少以及它介导这种作用的机制。
使用慢病毒介导的短发夹RNA(shRNA)在膀胱癌细胞中敲低FSIP1表达。使用蛋白质免疫印迹法、免疫组织化学(IHC)和定量逆转录聚合酶链反应(qRT-PCR)检测FSIP1表达。在体外使用集落形成、3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)和流式细胞术(FCM)凋亡试验以及在体内使用BALB/c裸鼠异种移植模型评估敲低FSIP1对肿瘤细胞的影响。
研究结果表明FSIP1蛋白在膀胱癌细胞系中高表达。敲低FSIP1导致膀胱癌细胞系的肿瘤细胞活力降低、细胞周期停滞在G/G期以及细胞凋亡(<0.05)。此外,敲低FSIP1表达抑制了膀胱癌异种移植瘤的形成和生长(<0.05)。在基因水平上,敲低FSIP1表达下调了PI3K/AKT信号通路的活性。
本研究表明,敲低FSIP1通过抑制PI3K/AKT信号通路在体外和体内抑制膀胱癌细胞的恶性行为,这表明靶向FSIP1可作为膀胱癌潜在治疗策略进一步评估。